The one-day course covers a variety of procedures, from forelimb, hindlimb and tail amputations, to enucleations and simple eyelid mass removals.
Graduates will also begin learning about the use of basic skin flaps to close larger wounds.
They will also be taught how to recognise a patient requiring urgent or emergency care and initiate evaluation and management.
Sarah Rutherford, Head of Clinical Education at CVS, said: “When we spoke to our graduates, they told us that they were keen for us to run this course, so that they could build experience and confidence in these common procedures, post their university and extra mural training.
“These are GP procedures. So, thinking about contextualised care, we felt it was important for all of our companion animal veterinary General Practitioners to offer these treatment options - no matter how many years they’d been practicing.
"It’s great to empower our new graduates to conduct these salvage-type procedures - rather than book them in with experienced, certified and advanced vets, or even a referrals specialist.
“It was also important for us to have GP vets Frances and Andy teaching our new surgical GP course, as they appreciate the challenges and practicalities of first opinion practice (FOP).
"It hopefully shows the opportunities that are available in teaching within CVS for all of our general practitioners.”
Hannah Spooner BVSc MRCVS, New Graduate Programme Lead said: "I recently took at poll at the Cambridge AVS congress this spring and this course came out on top - as the course students would ‘most be looking forward to’ if they were to join the CVS New graduate programme in the future. So that’s very encouraging to know!”
www.careerswithcvs.co.uk
VetSurgeon member Viki Edmondson MRCVS is taking part in a drive to help 13-year-old Octavia Woodward, who was born with spinal muscular atrophy (SMA), raise £100,000 to help The SMA Trust.
Viki, a well-known vet in the carriage driving world, will be joining Octavia on 'Octavia's Mad Marathon', a five-day, 110 mile carriage drive from Windsor to Wincanton.
Octavia will be driving her pony, Diddy, with her mother Henrietta as co-driver. Meanwhile, Viki will be driving a pair of Gelderlander horses. They'll be leaving the main ring at the Royal Windsor Horse Show with a support crew at 3:30pm on 13th May.
Viki graduated from Bristol Veterinary School in 1993. Since 2001 she has run her own equine practice plus a small animal surgery from the Newdigate, Surrey farm she shares with husband Peter. Viki has known Octavia since she was born and it was Viki who paired up Diddy with Octavia and encouraged her to progress from walking round the roads to the excitement of "off-roading". Viki will be providing support and encouragement to Octavia during the trip - of course with any veterinary help being close by.
To support Viki and Octavia, visit: http://www.justgiving.com/vikithevet
Boehringer Ingelheim has announced that its 'Talk About Laminitis' campaign will run from Mid March until the end of June.
Last year, the initiative saw over 9000 horses and ponies tested for PPID through its free ACTH test scheme. This year, to build on this success and support the testing of even more animals, the company has announced a high impact, co-ordinated campaign to drive awareness that up to 90% of laminitis cases may have an underlying endocrine cause1,2.
Once again, Boehringer is urging veterinary surgeons to carry out free ACTH blood tests on laminitic or foot-sore horses as part of the campaign, which is backed by Redwings, The British Horse Society and World Horse Welfare.
Professor Andy Durham from the Liphook Equine Hospital, where the ACTH tests are performed, said: "We are learning so much from these tests. For example, we are now recognising PPID routinely in laminitic horses and ponies as young as 10 years old, and in the spring when we might expect to see more EMS cases, where veterinary surgeons have also tested for PPID we are seeing both abnormally elevated ACTH and insulin. Unless the PPID is addressed, horses will continue to be at risk of painful recurrent laminitic episodes which is a significant welfare issue to the horse and extremely frustrating for owners."
To participate in the scheme, veterinary surgeons and horse owners can download ACTH blood test vouchers from www.talkaboutlaminitis.co.uk. Attach the voucher to the ACTH sample submission form and the ACTH laboratory fees will not be charged.
Lee Hackett from The British Horse Society said: "Without the 'Talk About Laminitis' initiative and the support of Boehringer Ingelheim, literally thousands of horses may not be receiving the appropriate treatment and management for their laminitis to help prevent recurrence. We hope as many veterinary surgeons as possible get involved this year to continue this welfare success."
To ensure that horse owners are fully aware of the initiative, a PR and advertising campaign in the equine consumer media will start in March. The ad campaign includes an infomercial on Horse & Country TV (SKY Channel 280), with viewer numbers in excess of 450,000 per month.
There will also be a live online broadcast for horse owners on endocrinopathic laminitis presented by David Rendle BVSc MVM CertEM(IntMed) DipECEIM MRCVS, from the Liphook Equine Hospital in Hampshire. The one-hour webinar, which takes place at 8.00pm on Wednesday 10 April, will educate horse owners on how the veterinary profession's understanding of this debilitating and devastating disease has been completely revolutionised over the past five years. It will be followed by an interactive Q&A session when viewers will be able to pose questions for David to answer.
David said: "As our knowledge of the two hormonal diseases responsible for the majority of cases of laminitis improves, veterinary surgeons can offer their clients more comprehensive advice on treatment options to prevent laminitis. For many owners who have struggled with this condition, this is an absolute revelation and has enormous welfare benefits".
Horse owners can register to view the online programme by visiting www.talkaboutlaminitis.co.uk.
To ensure that veterinary surgeons are versed in the most up to date research available, Boehringer Ingelheim will also be hosting a webinar for veterinary professionals at 8.00pm on Wednesday 13th March, presented by Professor Andy Durham BSc BVSc CertEP DEIM DipECEIM MRCVS. The online seminar, 'The laminitis revolution.... An update on our understanding of endocrinopathic causes of laminitis', will entitle the viewer to a downloadable certificate for one hour of CPD. To register, visit www.bi-academy.co.uk. Places are limited, so register early to avoid disappointment. The webinar will also be available to view after the event on demand.
For further information on how you can promote 'Talk About Laminitis' in your practice contact your Boehringer Ingelheim Territory Manager or call 01344 746959
References
1. Karikoski et al. (2011). The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion/referral equine hospital. Domestic Animal Endocrinology 41 111-117
2. Donaldson et al. (2004). Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis. J Am Vet Med Assoc;224:1123-1127.
The RCVS ERP provides an ethics review mechanism for researchers who are based in practice and don't have access to this process through university and industry connections.
The subcommittee has representation across a range of areas of veterinary expertise, including veterinary nursing, and also includes lay researchers and scientists.
Since its formation as a trial service in 2016, the ERP has reviewed more than 530 research proposals on behalf of the College.
Nicola said: “I am honoured to be offered this position.
"Having been a member of RCVS ERP for the past three years and undertaking a similar role as the Chair of the Clinical Research Ethical Review Board at the Royal Veterinary College, I felt that I had the right expertise to take on the role
“It is vitally important that all research, regardless of where it is undertaken, undergoes ethical review to ensure that robust results are produced especially when they have the potential to influence clinical practice, and so I really welcome the work the ERP has been undertaking.
“As chair of the ERP I hope to build on the success of my predecessor and continue to support those working in clinical practice that is not associated with a university to undertake valuable research and add to the body of evidence that supports our clinical decision-making.”
www.rcvs.org.uk/ethics
The RCVS has published a summary of the goings on at its 6 November meeting.
Amongst other things, Council agreed to continue to display postnominals in the Register, undertake a consultation on whether members should be able to use the courtesy title 'doctor' and make amendments to the College's current registration regulations.
In addition,
More information about these decisions can be found in the latest edition of RCVS News, copies of which have been sent to all veterinary surgeons and listed/registered veterinary nurses.
The full papers for the Council meeting can be found on the RCVS website at www.rcvs.org.uk/about-us/rcvs-council/council-meetings
Nominated by a colleague, Will graduated and joined the practice in 2021, having previously worked as a dairy herdsperson.
In his nomination, clients described Will as having an excellent understanding of the practicalities of running a herd, and said he provides realistic and achievable advice.
The judging panel was impressed by Will’s dedication to improving health, welfare, and productivity on dairy farms with his clear advice and workable action plans.
In addition, Will set up an embryo transfer service, bringing a new service to his practice, along with a robot discussion group, all of which have made a significant and positive impact to his dairy farming clients.
Will said: “It was a real privilege to be awarded the Young Dairy Vet of the Year award amongst so many talented and dedicated farm vets in our line of work.
"Above all it is a testimony to the farmers I work with day to day and the proactive attitude they take to improving their systems which has given me so many opportunities to develop my career”.
This year’s runner up was Hana Ward of Torch Vets in Barnstaple, Devon.
Photo: Will with last year's winner, Tom Warboys.
The practice was officially opened by the TV presenter and newspaper columnist, Adrian Chiles, who faced a lot of criticism from the profession a couple of years ago when he wrote an article about increasing veterinary fees and upselling tactics.
Adrian said: “I have never received such a volume of correspondence to one of my newspaper columns.
"One of the people that wrote to me was Movement Director, Professor John Innes, and we had very useful subsequent discussions that made me realise I had unfairly blamed vets for the issues I had felt as a pet owner.”
The new centre is led by Mark Lowrie, Specialist veterinary neurologist, who is joined by orthopaedic surgeons, Kinley Smith and David Thomson and neurology residents, Callum Golding and Rebecca Clark.
https://www.movementvets.co.uk
Dorwest Herbs has highlighted research that suggests a highly rational mode of action for kelp seaweed as an aid in the treatment of obesity when used alongside a weight reduction diet. The company is asking vets and nurses to look at the evidence and consider using licensed herbal medicines to help cats and dogs lose weight naturally. To help you evaluate the product, Dorwest is giving away 50 trial packs of Kelp Seaweed Tablets.
Mary Boughton MBE, Quality Director at Dorwest Herbs and the UK's leading specialist in the formulation of veterinary herbal medicines said: "We have lots of evidence that Kelp Seaweed Tablets work as an aid in the treatment of obesity but traditional explanations were based on the effect of iodine supplementation on thyroid function as a mode of action. That just didn't hold water for us. However, in common with many conventional medicines, the mechanisms for mode of action of herbal medicines are often not known. So, it was with some excitement that we heard of research that demonstrated that fucoxanthin, a pigment found in kelp, upregulates expression of UCP1 (uncoupling protein) and produces weight loss in the same region as conventional anti-obesity drugs."
Various studies estimate pet obesity may affect 30 to 60 per cent of pets in the UK and arthritis, heart disease and diabetes are just some of the diseases that occur with increasing frequency in obese pets. The research indicates that fucoxanthin has an effect on glucose metabolism and may lower the risk of coronary heart disease in humans. Phlorotannins found in brown seaweed have also recently been indentified as interfering with both the onset and consequences of osteoarthritis. Mary Boughton points out that multiple effects are often seen when herbal treatments are used, "Herbal treatments contain thousands of plant derived chemical compounds and are known for their diverse action, as opposed to the 'magic bullet' effect seen with conventional medicines. In a condition such as obesity where we see many disruptions of normal metabolism and several co-morbid conditions, choosing a herbal treatment makes sense. Kelp Seaweed Tablets are the logical alternative."
Dorwest has prepared a fully referenced technical information sheet detailing recent scientific studies and data from herbal formularies with reference to the role of kelp seaweed in obesity management.
To help vets and nurses further evaluate Kelp Seaweed Tablets - a licensed herbal medicine - used as part of a weight management programme the company is giving away 50 FREE trial packs containing seven weeks of Kelp Seaweed Tablets for a large breed dog, a case report sheet and the technical information sheet. There is also a prize of £100 of John Lewis shopping vouchers for the most informative case report received before the end of February 2010. There is one pack available per practice, while stocks last.
To request a technical information sheet or pack call Dorwest Herbs on 01308 897272.
For the first time BSAVA is running a Case Report Competition to be held at the annual Scottish BSAVA Congress (26-28th August 2011 at the Edinburgh Conference Centre).
Veterinary surgeons, nurses and students are invited to submit abstracts of no more than 400 words detailing a case and interesting discussion points.
Cases will then be selected for a short presentation at the congress
Successful selection will entitle the presenter to free congress registration on that day.
At the end of the session, a BSAVA manual of the winner's choice will be awarded to the case report deemed favourite by the audience.
Abstracts should be submitted via email by the 15 June 2011 and notification of acceptance will be given by the 30 June 2011.
Please send any enquires or submissions to Gerard McLauchlan (g.mclauchlan.1@research.gla.ac.uk) or Yvonne McGrotty (yvonne.mcgrotty@vets-now.com).
Elanco Animal Health has announced a revision to the canine Atopica SPC, designed to provide veterinary surgeons with more flexible treatment options for canine atopic dermatitis
The updated license now states that consideration should be given to the use of other measures and/or treatments to control moderate to severe pruritus when initiating therapy with Atopica.
Elanco says pruritus control can be provided by combining Atopica with anti-inflammatory doses of prednisolone, the safety and efficacy of which has been confirmed in a clinical study1 included on the updated Atopica package leaflet.
The company says the changes to the SPC have been made in recognition of the importance of understanding the underlying cause of the itch and whilst treating dermatology cases can be a complex process, good clinical practice suggests a tailored multi-modal approach depending on the individual case. This can be done in three stages:
Alice Laurens, DVM MRCVS, dermatology marketing manager at Elanco Animal Health, said: "Dermatology cases can be difficult to treat, however the new flexible approach and the ability to combine Atopica with prednisolone will swiftly help to control pruritus in the short-term and keep the pet comfortable in the long-term."
Further information about common dermatological conditions in dogs and cats, together with a diagnostic tool are available at: www.vetassistdermatology.com.
Reference
Zoetis Business Consulting has released figures showing that Profit Solver, its financial analysis tool, has delivered an average EBITDA (earnings before interest, taxes, depreciation and amortization) growth of 36% for the 28 UK practices that have used the new service since its launch.
Profit Solver was first launched in the USA, where the company says more than 300 practices have now benefited from the service.
Zoetis says that traditionally, veterinary practices have set their prices by simply adding a set mark-up, without knowing which services make a profit or loss and without understanding exactly how overall practice profit is being generated.
Profit Solver instead uses the practice’s own data to calculate the exact cost for the 130 most commonly performed veterinary services, representing 90% of the revenue generated by the practice. It then combines labour, inventory and equipment costs with time-and-motion studies for each service, and assesses the variance between cost and price to reveal profit or loss.
By using a collection of cost data, which staff perform which part of the procedure, how long the procedure takes and what equipment and materials are used, Profit Solver calculates the correct pricing to both cover costs and deliver a pre-determined profit margin.
Implementing Profit Solver is done with a Zoetis business consultant who guides the practice through the process, from data collection to examining the time-and-motion studies. They discuss the level of profitability the practice needs to deliver and help analyse prices to achieve this goal whilst preserving the price-point of highly competitive services and covering all the practice’s costs.
Ian Camm, Group Director of B&W Equine Vets in Gloucestershire heard about Profit Solver from a vet in a neighbouring practice who was impressed with how it had helped his business. Ian discussed Profit Solver with his Zoetis account manager and booked an appointment with Zoetis Business Consultant Anthea Pike who has helped him implement the software across B&W Equine Group.
He said: "Initially I was concerned that Profit Solver would suggest we put prices up where we felt that we would not be able to - people shop around for their veterinary services these days and many services are very price sensitive. The first stage in the process addressed this by looking at our figures, calculating the cost price for each procedure and then, by comparing with our fees charged, identified where we were losing money. The big question was whether we would be comfortable to increase our fees on loss-making procedures. The beauty of the system was that by looking at a large number of procedures which were done frequently, very small increases in fee would total to a significant improvement in the bottom line.
"The software has made us recognise where the real costs are and how to address these areas accordingly, for example we have identified that current stud packages are not profitable. One of the problems in arriving at true costs is the difficulty in accurately allocating time to various procedures when several different vets are involved or an expensive scanner is used, which can have a significant impact on the results. It’s early days, but I can already see the difference that Profit Solver could make to our bottom line and wouldn’t hesitate to recommend it providing the practice is prepared to make changes in light of the results. We are looking at improving our bottom line by a six figure sum over a 12 month period with what we hope, will be hardly noticeable price rises.”
For further information visit www.zoetis.co.uk/businessconsulting.
Bruce Bladon will describe current antibiotic use in equine practice, Victoria South will consider the use of Highest Priority Critically Important Antimicrobials, and Bettina Dunkel will describe strategies to reduce antimicrobial use.
The webinar is free for both members and non-members.
To register, visit: https://us02web.zoom.us/webinar/register/7016678281618/WN__XNTbcxoQ2K1mXUGOIVL_g
Photo: Safia Barakzai, Equine Surgeon
A one-day seminar entitled ‘One World, One Disease,’ will take place at the Royal Society of Medicine (RSM), Wimpole Street, London, on 24 June 2008.
The event, which has been jointly organised by the RSM and the Royal College of Veterinary Surgeons (RCVS), will examine some of the effects of climate change on patterns of animal health and the impact of this on humans. The meeting will provide an understanding of the complexity of the global changes that we face, and will work towards the integrated approach needed to manage the serious problems that threaten animal and human health.
About two-thirds of new infectious diseases that threaten humans come from animals. With global climate change, this looks set to increase. Now more than ever, it is important that veterinary and medical colleagues come together to discuss disease control strategies.
Speakers will include RCVS Senior Vice-President Professor Sheila Crispin, who has been instrumental in organising the conference, Caroline Lucas MEP, Professor Bob Watson, Defra’s Chief Scientific Adviser, the RVC’s Professor Quintin McKellar and Lt Col Tim Brookes from the Health Protection Agency, among others.
All are welcome. Tickets are available from the Royal Society of Medicine online at http://www.rsm.ac.uk/academ/e10-oneworld.php
Boehringer Ingelheim has released details of research presented at the 29th World Veterinary Congress which shows dogs with congestive heart failure (CHF) due to myxomatous mitral valve disease (MMVD) live longer when treated with pimobendan (Vetmedin®) compared with a commonly used ACE inhibitor.
The results of the QUEST trial, the largest international study of its kind to be conducted amongst dogs with congestive heart failure, are due to be published in the Journal of Veterinary Internal Medicine (JVIM) later this year.
The condition myxomatous mitral valve disease (MMVD) accounts for approximately 75% of all cases of CHF in dogs2. MMVD is associated with the thickening of the cusps of the mitral valve (one of the main one-way valves within the heart), affecting the flow of blood from the heart to the rest of the body. Although there is no cure for CHF due to MMVD, there are treatments available to manage the condition, improving the quality and length of the dog's life.
Professor Jens Häggström, lead investigator of the QUEST trial from the University of Uppsala, Sweden, commented that "the QUEST trial is a significant milestone in our efforts to reassure both, veterinarians and dog owners, that there is compelling evidence to show that pimobendan is an effective treatment for CHF that prolongs their dog's life and providing pet and owner with more quality time together."
The QUEST trial was a randomised, positive-controlled, multi-centre trial conducted at 28 sites across 11 countries, and is the largest study of its kind ever conducted in veterinary cardiology. The study compared a pimobendan group with a group treated with benazepril hydrochloride on top of background diuretic therapy. The trial spanned three years and followed dogs to death, euthanasia or treatment failure leading to withdrawal from the trial.
Research by Boehringer has also shown that over 50% of dog owners in the UK are unaware that their dog may be at risk of heart failure. Heart disease affects one in four dogs over seven years of age, and the lack of knowledge about this serious, life-threatening condition suggests that there is a need for better education amongst dog owners on how to recognise the disease, and how to maintain their dogs' heart health.
CPD Solutions has launched four topic-specific veterinary webinar clubs for the veterinary profession, available to view at www.veterinarywebinars.com.
For veterinary surgeons, there are three clubs, one focussing on neurology, another on orthopaedics, and a final one on small animal practice. There is a fourth webinar club for veterinary nurses and technicians.
Susie Coughlan, Managing Director at CPD Solutions said: "We have given a lot of thought to setting up these clubs so that they reflect what people really need from their CPD. Neurology and orthopaedics are always incredibly popular topics and many vets have told us that they feel that in these subject areas, rapid developments and new techniques can really change their approach to cases."
Each club provides a monthly live webinar, in afternoons or evenings and all webinars are available for club members to view after the live event at their convenience. Susie said: "We decided to limit the available webinars to one a month during the annual membership period because with the best will in the world, many vets and nurses have only a limited time available to spend on CPD and there is very little point in paying for a multitude of webinars that they will never have the time to attend. Part of the appeal of webinars is their low cost and value for money, although we know many vets and nurses put flexibility as to when and where they view as the most exciting attribute of webinar clubs."
CPD Solutions is offering a special launch price of £247 + VAT to anyone who joins a webinar club for one year before 10th October (after which, the price rises to £327 + VAT per club). The offer includes a free CD/DVD which the company says is packed with content relevant to the club topic. All members can also access the full back catalogue of webinars relating to the topic.
For more details or to join a webinar club visit www.veterinarywebinars.com or call 0151 328 0444.
BCF Technology has launched the Mindray DP-50 veterinary ultrasound system, a black and white entry level system that can be used in both the small animal and equine general practice.
According to the company, the DP-50 offers excellent black and white abdominal and cardiac images and the menu system for performing measurements, calculations and image review is very intuitive. The system allows you to save images and video clips to internal memory, as well as exporting to USB.
Nigel Perry from BCF said: "This is an excellent entry level system that provides high quality images at a great price - only £6,500 for the system including one probe. The Mindray DP-50's easy to use menu system and superb image makes this scanner such a useful tool for a general veterinary practice."
Angus McPherson from Lomond Hills Veterinary Practice in Fife said: "We were looking for a scanner that was mobile, easy to use and most importantly gave a good image. The scanner was delivered at 9.00am and by 9.30am we had used it on two dog cases. One with a pyometra and one with an enlarged abdomen."
The DP-50 is exclusively available through BCF. For more information, call +44 (0)1506 460 023 or visit www.bcftechnology.co.uk.
The President of the British Veterinary Association has written to the Badger Trust to clarify the BVA position on the pilot badger culls in England, stating that it will not be supporting the Trust's application for a judicial review.
The BVA Council agreed a position on the continuation of controlled shooting in the pilot areas on 16 April. The position states that the BVA could only support further culling using controlled shooting in the pilot areas if steps are taken to improve both its effectiveness and humaneness and if there is robust monitoring and collation of results and independent analysis and auditing by a non-governmental body. It also states that the BVA supports the Independent Expert Panel's (IEP) recommendations for improving effectiveness and humaneness and urges Defra to implement all the IEP's recommendations fully.
The BVA says that since 16 April, it has been in dialogue with Defra to seek assurances that these issues will be addressed, and those discussions are ongoing. It will not be taking a further position on the pilot culls until BVA Council has had the opportunity to consider Defra's plans in full, when they are made available.
In a press release dated 20th May, The Badger Trust CEO Dominic Dyer said: "It is not acceptable for the DEFRA Secretary of State to now push aside the concerns of both the Independent Expert Panel and the British Veterinary Association, by moving ahead with a further badger cull in Gloucestershire and Somerset this summer without any independent monitoring in place."
The BVA says it is concerned that this misrepresents its position, and has led to some media reports suggesting that the BVA has withdrawn its support for badger culling as part of the overall strategy to eradicate bovine TB. It has not. The BVA says it continues to believe that the TB eradication strategy for England will only be successful if we are able to use all of the available tools, including targeted, humane badger culling.
Virbac has announced the launch of Speed Trio, an in-house diagnostic test to enable the detection of FeLV (Feline Leukaemia Virus) antigens; anti-FIV (Feline Immunodeficiency Virus) and anti-FCoV (Feline Coronavirus) antibodies in 15 minutes.
The company says Speed Trio is designed to facilitate the diagnosis of immunosuppressive diseases, such as FIP (feline infectious peritonitis); when a cat tests positive for Feline Coronavirus and either FeLV or FIV it is at increased risk of developing FIP¹ and serological testing for all three diseases is the logical step.
Virbac says it has also enhanced the entire Speed range to further improve the readability of the tests and the brightness of the test bands.
Product Manager Madeline Haynes said: "The Speed range, which has been proven in practice for more than 20 years, offers a comprehensive suite of in-house diagnostic tests, which are easy to perform and highly cost-effective to use in practice.
"Speed Trio is not only a unique test combination that helps to facilitate diagnosis of immunosuppressive diseases but also boosts client satisfaction and can support practice profitability."
Every year, the RCVS invites members of the veterinary profession to apply to join the RCVS Fellowship.
Becoming a member of the Fellowship is a recognition of an individual’s contribution to the professions and their commitment to advancing the scientific achievements of the veterinary sector.
Everyone that applies to join the Fellowship needs to demonstrate the impact they have had throughout their career on the veterinary professions.
The Fellowship Credentials Panel is responsible for reviewing and scoring Fellowship applications and making recommendations for who should be approved.
Angharad Belcher, Director for Advancement of the Professions, said: “Being part of our Fellowship Credentials Panel is a great opportunity to see the huge amount of dedication to the profession that prospective Fellows have shown throughout their careers, and to then celebrate their achievements when they are successfully welcomed to the Fellowship later in the year”.
To apply to join the Fellowship Credentials Panel, download and complete the application form (https://www.rcvs.org.uk/fellowship/credentials-panel-recruitment-2022/), then email it to Ceri Chick, Senior Leadership Officer at c.chick@rcvs.org.uk with a CV by 5pm on 28 February 2022.
The RCVS has launched a survey to discover what the profession thinks it does well and what it could improve upon.
The confidential online survey asks about your recent interactions with the College, what you think the organisation does well and what can be improved upon.
The survey is one of several activities that the College is undertaking as part of its First-Rate Regulator initiative. Others include a survey amongst those who have made complaints; research amongst RCVS staff and Council / VN Council members; in-depth phone interviews with veterinary surgeons, veterinary nurses and practice managers; and, questionnaires aimed at stakeholder organisations that work regularly with the College.
Desk-based research is also being carried out, to see how the RCVS shapes up when compared to other similar regulators, both in the UK and overseas.
Following this evidence-gathering stage, an assessment will be made about where gaps exist between how the College performs and what it ought to be achieving, together with recommendations for change.
Nick Stace, RCVS CEO said: "Becoming a first-rate regulator is the aim, building on the good things we do, and challenging ourselves to be better where we fall short."
"Although the RCVS has a long and proud history, we also need to have a sustainable future. Careful scrutiny of what we do, and how we can improve, will ensure this. I would urge all members of the veterinary team to take this unique opportunity to help improve the regulation of their professions."
The survey closes on 4 January 2013. All veterinary surgeons and veterinary nurses for whom the RCVS holds unique email addresses will be sent a link to the survey. Others are invited to visit www.rcvs.org.uk/firstratesurvey to take part. Practice managers, and student vets and VNs are also encouraged to complete the survey. Individuals who are not veterinary surgeons, nurses, students or practice managers, and who have views about how the College could improve, are invited to contact Nick Stace on nick@rcvs.org.uk.
Alstoe Animal Health has launched Dolagis, a carprofen tablet for dogs that uses a unique delivery system which the company claims offers palatability and dosage benefits over other versions of this analgesic.
Called Delicament, the delivery system is essentially a clever tablet design which allows a single table to break easily and accurately into four pieces. That allows correct dosing for all dogs above 3kg, from just one tablet size. Delicament has also been designed to be highly palatable, both in terms of flavour (pig's liver, before you ask) and texture.
To further simplify practice stocking requirements, Dolagis comes in only one pack size, complete with dispensing envelopes that explain how to split the tablet.
Dolagis 50mg tablets are packed in individually perforated blister strips of 10 tablets to aid prescribing accuracy and product integrity. This also reduces the chance that high palatability can lead to patient self-consumption. There are 100 tablets per Dolagis pack, which are available from all wholesalers. For further information contact Alstoe on 01347 878606 or email info@alstoe.co.uk.
The Horse Trust is funding a three-year project to develop a genetic diagnostic test for Fell Pony Syndrome (FPS) and thus enable control and possible elimination of the disease.
The work will be undertaken at the Animal Health Trust, Newmarket, and the University of Liverpool Veterinary School.
The Fell pony, an ancient British pony breed categorised as "at risk" by the Rare Breeds Survival Trust, has over the past decade or so been subject to a severe immune deficiency known as Fell Pony Syndrome (FPS), which results in the death of some of the newborn foals.
Foals affected with FPS appear normal at birth but within a few weeks begin to lose condition and suffer diarrhoea, coughing and weight loss. Severe anaemia and immune dysfunction follows, leading to wasting and finally death. The disease is always fatal.
As a large percentage of these ponies live and breed on the fell, the prevalence of FPS is unclear. Despite an improvement in foal registration numbers in recent years, Fell Pony Syndrome remains of concern to breeders.
Studbook analysis and knowledge of affected foals strongly suggests that this is an inherited disease caused by an autosomal recessive genetic mutation. A DNA based test for this mutation would enable carriers of FPS to be identified and the conception of affected foals prevented.
As well as identifying carriers in the Fell pony population, the project will be used to identify any carriers in other breeds which have been involved in the extensive outbreeding of Fell ponies over the years.
"The success of this project will prevent the suffering of newborn Fell pony foals affected with FPS," says project leader Dr June Swinburne, senior post- doctoral equine molecular geneticist at the Animal Health Trust Centre for Preventive Medicine. "Foals affected by the condition inherit an incurable genetic defect which results in severe wasting and a profound anaemia together with multiple infections. Veterinary intervention is in vain and once the condition is diagnosed foals are often euthanased. The gradual but relentless decline in these foals leaves both veterinary surgeons and breeders powerless.
"Breeders are supportive of our attempt to develop a diagnostic test which will help to prevent carrier-carrier matings, one in four of which results in an affected foal."
The Horse Trust's Chief Executive and resident veterinary surgeon Paul Jepson said: "This is an exciting and achievable project with significant benefits for equine health and welfare, as it will lead to the prevention and elimination of a fatal disease."
The EAEVE (European Association of Establishments for Veterinary Education) has granted full accreditation to the Royal Veterinary College.
The RVC is the only one in the world to have achieved full accreditation by EAEVE and the American Veterinary Medical Association (AVMA), and full recognition by the UK's Royal College of Veterinary Surgeons.
Accreditation by EAEVE provides Europe-wide assurance of academic standards. Three other European veterinary schools have achieved accredited status: Copenhagen, Helsinki and Zurich/Bern.
Avacta Animal Health and the University of Leicester have announced the development of a new, user-friendly electronic system for diagnosing lymphoma in dogs in the early stages, and for remission monitoring.
Marketed as cLBT (canine lymphoma blood test), this is the first test of its kind to track the remission monitoring status of a dog after undergoing chemotherapy. The test detects the levels of two biomarkers, the acute phase proteins C-Reactive Protein and Haptoglobin.
The new test represents the fruits of a collaboration between Avacta and the University of Leicester in which the company collected a substantial library of biological samples, and the University then brought its statistical and data processing techniques to bear.
Alexander Gorban, Professor of Applied Mathematics at the University of Leicester, said: "This was a very interesting project, and Avacta was a very dedicated, focused company, with clear goals and objectives. There were very important and useful ideas and concepts involved in the study, and it was a pleasure to know that our expertise as a department was needed and could be utilised through working alongside Avacta's professional expertise.
"The project was very successful, and we would be very glad to welcome more partnerships of this type as it has also been very beneficial to the reputation of the University of Leicester's Department of Mathematics. The project involved full academic and commercial success, which has included a full academic cycle as well as full software development, which makes it an incredibly diverse project to have worked on."
Chief Scientific Officer at Avacta Animal Health, Kevin Slater, said: "The collaboration we have with the University of Leicester's Department of Mathematics is having a dramatic impact on the types of new tests that we can offer to vets and their owners. We are already widening the application of multivariate analysis to other diseases which commonly affect our pets, and subsequently, this work could also have benefits to human health."
The paper 'Computational diagnosis and risk evaluation for canine Lymphoma' by E.M. Mirkes, I. Alexandrakis, K. Slater, R. Tuli and A.N. Gorban has been published in the academic journal Computers for Biology and Medicine and is available at the following location: http://dx.doi.org/10.1016/j.compbiomed.2014.08.006
Now, when you advertise a job on VetSurgeon.org, the system can send a message to all your employees (and any contacts in the profession) asking them to pass it on if they know anyone suitable, and to share the advertisement on their other social networks, such as Facebook.
As a further option, practices can also now offer a cash reward for a successful introduction leading to the post being filled. In that case, the message sent to employees and contacts lets them know that there’s a reward for their help.
VetSurgeon.org Editor Arlo Guthrie said: "Since we relaunched VetSurgeon Jobs, I’ve noticed a correlation between the number of times that job advertisements are shared by email or on Facebook, and the success that practices have in filling the vacancy.
"Of course, there is nothing to stop you emailing staff and contacts yourself, or offering a reward. But I suspect many don’t, and my hope is that this new feature will really help focus the mind, streamline the process and ultimately help you find the person who'll fit in with your team."
"Share & Reward is another feature exclusively available on VetSurgeon Jobs, alongside the VetSurgeon Locums Map and Find Our Jobs on VetSurgeon (a badge for your website that links to just your jobs).
"There's more on the way!"